Immatics N.V.

NASDAQ:IMTX

Biotechnology

Healthcare
$5.95 +1.58%

+$0.15 today

Market cap
$890.33M
Beta
1.30
P/E (TTM)
-5.3
EPS (TTM)
-$1.59
52W Low $5.05High $12.41

Volume 0.99M

Average 0.46M

Cash Flow

Check whether earnings turn into cash.

Operating Cash Flow

-$169.66M

FY 2025 · Annual

Investing Cash Flow

$196.70M

FY 2025 · Annual

Financing Cash Flow

$93.51M

FY 2025 · Annual

-70.7% YoY

Cash Flow Statement

EUR
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(93.34M)37.51M(94.65M)15.22M(188.69M)
Depreciation & Amortization5.26M6.97M7.23M12.23M11.91M
Deferred Income Tax11.15M4.52M06.13M0
Stock-Based Compensation26.4M22.57M20.71M17.64M0
Change in Working Capital(31.7M)37.26M81.63M(163.88M)(42.23M)
Accounts Receivables569K(429K)(2.98M)(1.76M)(232.45K)
Inventory00(84.24M)00
Accounts Payables(31.78M)45.56M84.24M0(36.13M)
Other Working Capital(483K)(7.87M)84.61M(162.11M)(5.87M)
Other Non-Cash Items433K(8.7M)3.31M(45.37M)49.36M
Operating Cash Flow(81.78M)100.13M18.23M(158.03M)(169.66M)
Capital Expenditures(5.66M)(6.22M)(30.96M)(16.48M)(6.3M)
Acquisitions (Net)551K(199.91M)000
Purchases of Investments(11.3M)(216.32M)(415.33M)(450.35M)(324.92M)
Sales of Investments24.45M12.7M414.74M314.44M528.16M
Other Investing Activities(551K)199.96M(8K)(206K)0
Investing Cash Flow7.49M(209.79M)(31.39M)(152.39M)196.7M
Debt Repayment(2.71M)(2.84M)(3.85M)(2.01M)0
Common Stock Issued94K134.48M90.4M343.01M96.35M
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities0(7.93M)(2.04M)(21.31M)(2.84M)
Financing Cash Flow(2.61M)123.71M84.52M319.68M93.51M
Effect of Forex Changes2.37M1.48M(1.4M)9.01M16.56M
Net Change in Cash(74.54M)15.53M69.95M18.28M137.12M
Free Cash Flow(87.44M)93.92M(12.73M)(174.51M)(175.95M)

Free Cash Flow

Net Income to FCF bridge

FY2025

= Net Income-$188.7M
+ D&A$11.9M
+ Stock-Based Comp$0
+ Deferred Tax$0
- Working Capital-$42.2M
+ Other Non-Cash$49.4M
= Operating Cash Flow-$169.7M
- Capex-$6.3M
= Free Cash Flow-$176.0M

Analysis

FY2025 free cash flow is -$176.0M. FCF conversion is 93.2% of net income. Operating cash flow was -$169.7M, with capex of -$6.3M. The largest bridge item is Other Non-Cash at $49.4M.

Recent Filings

Recent regulatory filings

FilingDescriptionDate
SC 13G/ASC 13G/A filingNov 13, 2026
6-K6-K filingNov 10, 2026
6-K6-K filingOct 26, 2026
6-K6-K filingOct 23, 2026
4Statement of changes in beneficial ownershipAug 27, 2026

Does IMTX generate free cash flow?

Immatics N.V. (IMTX) generated -$175.95M of free cash flow in fiscal 2025.

How much operating cash flow does IMTX produce?

Operating cash flow was -$169.66M, before capital expenditures of $6.30M.